Brief: Alvotech And Teva Secure U.S. License Date For AVT04

Alvotech SA

12/06/2023 08:03

June 12 (Reuters) - 
  
    * ALVOTECH AND TEVA SECURE U.S. LICENSE DATE FOR AVT04, A
PROPOSED
BIOSIMILAR TO STELARA®
    * ALVOTECH - CO AND TEVA PHARMACEUTICALS, INC., ANNOUNCED
REACHED 
SETTLEMENT AND LICENSE AGREEMENT WITH JOHNSON & JOHNSON
CONCERNING AVT04
    * ALVOTECH - SETTLEMENT GRANTS A LICENSE ENTRY DATE FOR
AVT04 IN
UNITED STATES NO LATER THAN FEBRUARY 21, 2025
    * ALVOTECH - ACCORDING TO SETTLEMENT AGREEMENT, AVT04
(USTEKINUMAB) CAN BE MARKETED IN US, SUBJECT TO REGULATORY
APPROVAL, NO LATER THAN FEB 21, 2025

Source text for Eikon:  ID:nGNXb5B9Hx 
Further company coverage:  JNJ.N 

 ((Reuters.Briefs@thomsonreuters.com;))